TG Therapeutics to Participate in the 2023 Jefferies Healthcare Conference
05 Juin 2023 - 1:30PM
TG Therapeutics, Inc. (NASDAQ: TGTX) today announced that Michael
S. Weiss, the Company’s Chairman and Chief Executive Officer, will
participate in the 2023 Jefferies Healthcare Conference, being held
at the Marriott Marquis Hotel, in New York City on June 7th – 9th,
2023. The fireside chat is scheduled to take place on Wednesday,
June 7, 2023, at 11:30 AM ET.
A live webcast of the fireside chat will be
available on the Events page, located within the Investors &
Media section, of the Company’s website at
http://ir.tgtherapeutics.com/events.
ABOUT TG THERAPEUTICSTG
Therapeutics is a fully integrated, commercial stage,
biopharmaceutical company focused on the acquisition, development
and commercialization of novel treatments for B-cell diseases. In
addition to a research pipeline including several investigational
medicines, TG has received approval from the U.S. FDA for BRIUMVI®
(ublituximab-xiiy), for the treatment of adult patients with
relapsing forms of multiple sclerosis, to include clinically
isolated syndrome, relapsing-remitting disease, and active
secondary progressive disease. For more information,
visit www.tgtherapeutics.com, and follow us on
Twitter @TGTherapeutics and on LinkedIn.
CONTACT:
Investor RelationsEmail:
ir@tgtxinc.comTelephone: 1.877.575.TGTX (8489), Option 4
Media Relations:Email:
media@tgtxinc.comTelephone: 1.877.575.TGTX (8489), Option 6
TG Therapeutics (NASDAQ:TGTX)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024
TG Therapeutics (NASDAQ:TGTX)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024
